U.S. Ophthalmic Drug Delivery Systems Market, 2025-2030
The ophthalmic drug delivery systems market in the United States is expected to reach a projected revenue of US$ 10,438.2 million by 2030. A compound annual growth rate of 6% is expected of the United States ophthalmic drug delivery systems market from 2026 to 2030.
- MedTech
- Drug Delivery Devices
- ophthalmic drug delivery systems market report
- Drug Delivery Devices
Revenue, 2025 (US$M)
$7,783.1
Forecast, 2030 (US$M)
$10,438.2
CAGR, 2026 - 2030
6.0%
Report Coverage
U.S.
U.S. Ophthalmic Drug Delivery Systems Market, 2018-2030 (US$M)
Global Market
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the ophthalmic drug delivery systems market report market
Every figure cited from GVR research
U.S. ophthalmic drug delivery systems market highlights
- The U.S. ophthalmic drug delivery systems market generated a revenue of USD 7,783.1 million in 2025 and is expected to reach USD 10,438.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6% from 2026 to 2030.
- In terms of segment, eye drops was the largest revenue generating technology in 2025.
- Contact lenses is the most lucrative technology segment registering the fastest growth during the forecast period.
Ophthalmic drug delivery systems market data book summary
| Market revenue in 2025 | USD 7,783.1 million |
| Market revenue in 2030 | USD 10,438.2 million |
| Growth rate | 6% (CAGR from 2026 to 2030) |
| Largest segment | Eye drops |
| Fastest growing segment | Contact lenses |
| Historical data | 2018 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Eye drops, Contact lenses, Punctal plugs, Episcleral Implants, Intravitreal Implants, Injectable Particulate Systems, Iontophoresis, Micro-Electromechanical, Nano careers, Nano microparticles, Microneedles, Hydrogels |
| Key market players worldwide | Ocular Therapeutix Inc, Allergan, Santen Pharmaceutical Co Ltd, Clearside Biomedical Inc, Oculis Holding AG, Bausch Health Companies Inc, AptarGroup Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 45.8% of the global ophthalmic drug delivery systems market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. ophthalmic drug delivery systems market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,673.5 million by 2030.
No credit card required*
Publish Date: Mar 11, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ophthalmic Drug Delivery Systems Market Report
Ophthalmic drug delivery systems market report segmentation & scope
Others
Others
Others
Ophthalmic Drug Delivery Systems Market Report Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| AptarGroup Inc | View profile | 13,800 | 265 Exchange Drive, Suite 301, Crystal Lake, IL, United States, 60014 | www.aptar.com |
| Allergan | View profile | 10001+ | Madison, Wisconsin, United States, North America | www.allergan.com |
| Ocular Therapeutix Inc | View profile | 267 | 15 Crosby Drive, Bedford, MA, United States, 01730 | www.ocutx.com |
| Bausch Health Companies Inc | View profile | 20,270 | 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 | www.bauschhealth.com |
| Santen Pharmaceutical Co Ltd | View profile | 1,807 | Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, Japan, 530-8552 | www.santen.co.jp |
| Clearside Biomedical Inc | View profile | 30 | 900 North Point Parkway, Suite 200, Alpharetta, GA, United States, 30005 | www.clearsidebio.com |
| Oculis Holding AG | View profile | 36 | Bahnhofstrasse 7, Zug, Switzerland, 6300 | www.oculis.com |
U.S. ophthalmic drug delivery systems market report
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Ophthalmic Drug Delivery Systems Market will help companies and investors design strategic landscapes.
Eye Drops was the largest segment with a revenue share of 20.15% in 2025.
Horizon Databook has segmented the U.S. ophthalmic drug delivery systems market based on eye drops, contact lenses, punctal plugs, episcleral implants, intravitreal implants, injectable particulate systems, iontophoresis, micro-electromechanical, nano careers, nano microparticles, microneedles, hydrogels covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Ophthalmic Drug Delivery Systems Market Technology Outlook (Revenue, USD Million , 2018-2030)
- Eye drops
- Contact lenses
- Punctal plugs
- Episcleral Implants
- Intravitreal Implants
- Injectable Particulate Systems
- Iontophoresis
- Micro-Electromechanical
- Nano careers
- Nano microparticles
- Microneedles
- Hydrogels
- Others
- U.S. Ophthalmic Drug Delivery Systems Market Delivery Route Outlook (Revenue, USD Million , 2018-2030)
- Intraocular
- Intravitreal
- Intracameral
- U.S. Ophthalmic Drug Delivery Systems Market Production Technology Outlook (Revenue, USD Million , 2018-2030)
- Electrospinning
- 3D printing
- Extrusion
- Formulation
- Micro patterning
- Compression molding
- Others
- U.S. Ophthalmic Drug Delivery Systems Market Material Outlook (Revenue, USD Million , 2018-2030)
- Liposomes
- Collagen
- PLA-PEG
- PDO/PVA
- Hydrogels
- TMC
- Polyorthoesters
- PLGA
- Polycaprolactone
- Fatty acids
- Others
Reasons to subscribe to ophthalmic drug delivery systems market report databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of ophthalmic drug delivery systems market report databook
- Our clientele includes a mix of ophthalmic drug delivery systems market report companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. ophthalmic drug delivery systems market report, including forecasts for subscribers. This country databook contains high-level insights into U.S. ophthalmic drug delivery systems market report from 2018 to 2030, including revenue numbers, major trends, and company profiles.
U.S. Ophthalmic Drug Delivery Systems Market, 2018-2030 (US$M)
U.S. ophthalmic drug delivery systems market statistics, by technology, 2018-2030 (US$M)
